Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

ROTACUT Study: Rotational Atherectomy with Cutting Balloon for Stent Expansion Optimization

Approximately 30% of patients undergoing percutaneous coronary intervention (PCI) present moderate to severe calcified lesions, which presents a significant challenge involving a high incidence of major adverse cardiovascular events (MACE). Rotational atherectomy (RA) is used to modify these calcified lesions and facilitate balloon angioplasty followed by stent implantation. The combination of RA with other plaque prepping devices might improve outcomes in the long run. 

Estudio ROTACUT: Aterectomía rotacional con ¨cutting balón¨para optimizar expansión del stent

The aim of this prospective randomized study was to look into whether the combination of RA with cutting balloon (RA + CBA) results in better stent expansion vs. RA followed by non-compliant balloon (RA + NCBA).

Primary end point was minimum stent area after intervention, assessed by IVUS. Secondary end point included segment minimal lumen area, stent expansion, any dissection and malapposition. Researchers looked at 30-day clinical outcomes, including all-cause mortality, acute myocardial infarction, target vessel revascularization, instent thrombosis, major bleeding and vascular complications.

60 patients were randomized: 29 were treated with RA + CBA and 31 with RA + NCBA. Mean age was 71, and they were mostly men. Baselines characteristics in both groups were similar, with close to 60% of patients presenting single vessel disease and close to 20% presenting triple vessel disease. The most treated artery was the anterior descending in most patients, followed by the right coronary.

Read also: Drug-Coated Balloons (DCB): Sirolimus vs. Paclitaxel in De Novo Lesions in Small Vessels.

As regards primary end point, minimum stent lumen area was similar in both groups, with 6.7 ± 1.7 mm2 for RA + CBA patients and 6.9 ± 1.8 mm2 for RA + NCBA patients (p=0.685). Also, there were no differences in secondary end point. As regards clinical complications, there were two AMIs and one target vessel revascularization among RA + CBA patients and one AMI in the RA + NCBA group.

Conclusion 

In conclusion, the combination of RA with cutting balloon resulted in similar minimum stent area vs. RA followed by non-compliant balloons in patients with coronary lesions with moderate to severe calcification. RA followed by cutting balloon resulted safe, with few post procedural complications, and few adverse clinical events at 30 days. 

Dr. Andrés Rodríguez

Dr. Andrés Rodríguez.
Member of the Editorial Board of SOLACI.org.

Original Title: Rotational atherectomy with cutting balloon to optimize stent expansion in calcified lesions: The ROTACUT randomized trial

Reference: Samin K Sharma, MD et al EuroIntervention 2023;19:1-1.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...